CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement
- 13 February 2021
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (4) , 341-348
Abstract
There is not enough data on the effect of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) on lung involvement in patients with COVID-19 pneumonia and hypertens...Keywords
Funding Information
- The authors have no funding to report
This publication has 22 references indexed in Scilit:
- CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) PneumoniaRadiology, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive ratsJournal of Cellular and Molecular Medicine, 2015
- Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor BlockadeHypertension Research, 2008
- Angiotensin-converting enzyme 2 in lung diseasesCurrent Opinion in Pharmacology, 2006
- Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II ReceptorsHypertension, 2004